109 related articles for article (PubMed ID: 3157826)
1. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I].
Huth E
Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826
[TBL] [Abstract][Full Text] [Related]
2. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
Buschard K
Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
[TBL] [Abstract][Full Text] [Related]
3. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
Bretzel RG
Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
[TBL] [Abstract][Full Text] [Related]
4. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
5. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
6. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
Phillips BE; Giannoukakis N; Trucco M
Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
[TBL] [Abstract][Full Text] [Related]
8. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
[TBL] [Abstract][Full Text] [Related]
9. [Diabetes mellitus as a primary and secondary metabolic disease].
Lohmann D
Z Gesamte Inn Med; 1986 Oct; 41(20):565-7. PubMed ID: 3548098
[TBL] [Abstract][Full Text] [Related]
10. [Immunology of type-1 diabetes. The initial stages in a causal therapy].
Scherbaum WA; Hedderich U; Pfeiffer EF
Dtsch Med Wochenschr; 1986 Apr; 111(15):593-6. PubMed ID: 3514198
[No Abstract] [Full Text] [Related]
11. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease].
Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M
Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777
[TBL] [Abstract][Full Text] [Related]
12. Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.
Eisenbarth GS; Srikanta S; Jackson R; Rabinowe S; Dolinar R; Aoki T; Morris MA
Diabetes Res; 1985 Nov; 2(6):271-6. PubMed ID: 3878262
[TBL] [Abstract][Full Text] [Related]
13. [Clinical heterogeneity of childhood diabetes in Baranya county].
Makovi H; Soltész G; Hermann R
Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
[TBL] [Abstract][Full Text] [Related]
14. White cells transfusion in recent onset type 1 diabetes.
Pozzilli P; Ghirlanda G; Manna R; Alfano G; Greco AV; Andreani D
Diabetes Res; 1986 Jun; 3(5):273-6. PubMed ID: 2943548
[TBL] [Abstract][Full Text] [Related]
15. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
Diem P
Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
[TBL] [Abstract][Full Text] [Related]
16. Immunological disorders of type 1 diabetes mellitus.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
[TBL] [Abstract][Full Text] [Related]
17. On the pathogenesis of type 1 (insulin-dependent) diabetes mellitus: facts, areas still under development and new perspectives.
Bottazzo GF; Bonifacio E; Wagner R; al-Sakkaf L; Dean BM; Mirakian R
Klin Wochenschr; 1990; 68 Suppl 21():26-37. PubMed ID: 2198388
[TBL] [Abstract][Full Text] [Related]
18. Specific immunotherapy in insulin-dependent diabetes mellitus (preliminary report).
Lohmann D; Bierwolf B; Krug J; Lampeter E; Verlohren HJ
Exp Clin Endocrinol; 1986 Aug; 87(3):333-6. PubMed ID: 3536537
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for insulin-dependent diabetics?
Rossini AA
N Engl J Med; 1983 Feb; 308(6):333-5. PubMed ID: 6337326
[No Abstract] [Full Text] [Related]
20. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
